-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
F-star Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2017 to Q3 2022.
- F-star Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2022 was 21.9M shares, a 6.01% increase year-over-year.
- F-star Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2019 was 16.5M shares, a 12.6% increase from 2018.
- F-star Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2018 was 14.6M shares, a 31.1% increase from 2017.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)